Search

Your search keyword '"Peytavin, G."' showing total 754 results

Search Constraints

Start Over You searched for: Author "Peytavin, G." Remove constraint Author: "Peytavin, G."
754 results on '"Peytavin, G."'

Search Results

51. Multimorbidity in Elderly Persons According to the Year of Diagnosis of Human Immunodeficiency Virus Infection: A Cross-sectional Dat’AIDS Cohort Study

53. Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death

55. HIV-1 integrase variability and relationship with drug resistance in antiretroviral-naive and -experienced patients with different HIV-1 subtypes

58. Cellular HIV-1 DNA quantification and short-term and long-term response to antiretroviral therapy

60. Persistent low-level viraemia in antiretroviral treatment-experienced patients is not linked to viral resistance or inadequate drug concentrations

61. Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH)

72. Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?

73. Integrase strand transfer inhibitors and neuropsychiatric adverse events in a large prospective cohort

74. Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study

75. Prevalence of pretreatment HIV drug resistance in West African and Southeast Asian countries

77. Infections II

83. Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen

84. Safety study and therapeutic drug monitoring of the oral tablet formulation of posaconazole in patients with haematological malignancies

85. First line raltegravir/emtricitabine/tenofovir combination in HIV-2 infection: phase 2 non-comparative trial (ANRS 159 HIV-2)

87. HIV-1 integrase variability and relationship with drug resistance in antiretroviral-naive and -experienced patients with different HIV-1 subtypes

88. Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma

89. Pharmacokinetics and Safety of Darunavir/Ritonavir in HIV-Infected Pregnant Women

90. Letermovir breakthroughs during the French Named Patient Programme: interest of monitoring blood concentration in clinical practice.

91. Long-term follow-up of HIV-infected patients on dolutegravir monotherapy.

93. Prevalence and clinical impact of minority resistant variants in patients failing an integrase inhibitor-based regimen by ultra-deep sequencing

95. Évolution des marqueurs rénaux sous dolutégravir ou l’association emtricitabine/ténofovir/elvitégravir/cobicistat et corrélation avec les concentrations plasmatiques d’antirétroviraux

Catalog

Books, media, physical & digital resources